Media appearances connected to work with PrEP4All:

CNN.com, “Covid-19 drug rationed in the US is plentiful in developing countries.” (September 9, 2020)

STAT News, “With remdesivir, Gilead finds itself at strategic crossroads, with its reputation (and far more) at stake.” (May 5, 2020)

TheBody, “PrEP Advocates Call New Gilead Patent Suit Against HHS a ‘Distraction.’” (May 4, 2020)

Bloomberg Law, “Facebook Ads Cause Patients to Stop, Switch HIV Prevention Drug.”  (December 16, 2019)

The Advocate, “PrEP4All Claims Gilead Held Back Safer HIV Drug.” (December 5, 2019)

Washington Post, “Gilead delayed safer HIV drug to extend monopoly profits, advocates allege.”  (December 5, 2019)

Modern Healthcare, “Gilead pledges to donate Truvada despite HHS patent lawsuit.”  (November 7, 2019)

NBC News, “U.S. sues Gilead, claiming it owns HIV PrEP patent.”  (November 7, 2019)

Financial Times, “Gilead did not seek US exclusivity on PrEP with Truvada.” (August 18, 2019)

STAT News, “HHS gets a new HIV prevention patent, but will the agency demand royalties from Gilead?” (July 2, 2019)

Bloomberg News, “Gilead’s $21,000 Drug Is Being Blamed for a Plateau in HIV Prevention.” (May 17, 2019)

Bloomberg Law, “HIV Pill Patent Gives Trump Team Leverage in Gilead Price Talks.”  (April 12, 2019)

STAT News, “AIDS activists skewer CDC for conflicting stance on collecting HIV drug royalties.” (April 10, 2019)

Washington Post, “An HIV treatment cost taxpayers millions. The government patented it. But a pharma giant is making billions.” (March 26, 2019)



Media appearances connected to work with Charles Seife and Peter Lurie:

BMJ, “FDA may fine clinical trial sponsors that don’t report data.”  (August 24, 2020)

STAT News, “FDA finalizes penalties for clinical trial sponsors that don’t share data, but critics say they fall short.”  (August 18, 2020)

STAT News, “Following court ruling, NIH warns drug and device companies to post missing trial data.”  (August 4, 2020)

Endpoints News, “Clinical trial sponsors have to disclose decade’s worth of unreleased data, federal judge rules.”  (February 26, 2020)

STAT News, “Federal judge rules clinical trial sponsors must publish a decade’s worth of missing data.”  (February 25, 2020)



Other media appearances:

Bloomberg Law, “Pandemic Lays Bare Fight Over Patent Strength, Innovation.”  (August 11, 2020)

Politico, “Trump’s Wild West approach to virus cure-alls is a game-changer for drugmakers.” (April 17, 2020)

STAT News, “Academics and consumer groups protest FDA plan to summarize review documents.” (August 29, 2019)








Mark